BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31291891)

  • 1. The difference in serum proteomes in schizophrenia and bipolar disorder.
    Smirnova L; Seregin A; Boksha I; Dmitrieva E; Simutkin G; Kornetova E; Savushkina O; Letova A; Bokhan N; Ivanova S; Zgoda V
    BMC Genomics; 2019 Jul; 20(Suppl 7):535. PubMed ID: 31291891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlations between clinical features of bipolar affective disorder and serum concentrations of ANKRD12 gene product, coagulation factor XIII, and cadherin 5].
    Seregin AA; Smirnova LP; Dmitrieva EM; Boksha IS; Savushkina OK; Simutkin GG; Ivanova SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):137-142. PubMed ID: 36440791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
    Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
    Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls.
    García-Álvarez L; Caso JR; García-Portilla MP; de la Fuente-Tomás L; González-Blanco L; Sáiz Martínez P; Leza JC; Bobes J
    Eur Psychiatry; 2018 Jan; 47():50-59. PubMed ID: 29102659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplifying the human serum proteome for discriminating patients with bipolar disorder of other psychiatry conditions.
    de Jesus JR; Galazzi RM; de Lima TB; Banzato CEM; de Almeida Lima E Silva LF; de Rosalmeida Dantas C; Gozzo FC; Arruda MAZ
    Clin Biochem; 2017 Dec; 50(18):1118-1125. PubMed ID: 28662995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders.
    Steen NE; Methlie P; Lorentzen S; Dieset I; Aas M; Nerhus M; Haram M; Agartz I; Melle I; Berg JP; Andreassen OA
    J Psychiatr Res; 2014 May; 52():57-62. PubMed ID: 24534618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proton magnetic resonance spectroscopy study in schizoaffective disorder: comparison of bipolar disorder and schizophrenia.
    Kalaycı D; Ozdel O; Sözeri-Varma G; Kıroğlu Y; Tümkaya S
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):176-81. PubMed ID: 22306485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
    Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
    Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
    Novikova SI; He F; Cutrufello NJ; Lidow MS
    Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Proteomic Measures Across Serious Psychiatric Illness.
    Schulz SC; Overgaard S; Bond DJ; Kaldate R
    Clin Schizophr Relat Psychoses; 2017; 11(2):103-112. PubMed ID: 28742394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diurnal cortisol variation and cortisol response to an MRI stressor in schizophrenia and bipolar disorder.
    Girshkin L; O'Reilly N; Quidé Y; Teroganova N; Rowland JE; Schofield PR; Green MJ
    Psychoneuroendocrinology; 2016 May; 67():61-9. PubMed ID: 26874562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients.
    Vogel M; Pfeifer S; Schaub RT; Grabe HJ; Barnow S; Freyberger HJ; Cascorbi I
    Neuropsychobiology; 2004; 50(4):305-10. PubMed ID: 15539862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognition in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
    Jiménez-López E; Aparicio AI; Sánchez-Morla EM; Rodriguez-Jimenez R; Vieta E; Santos JL
    J Affect Disord; 2017 Nov; 222():169-176. PubMed ID: 28709024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased systemic cortisol metabolism in patients with schizophrenia and bipolar disorder: a mechanism for increased stress vulnerability?
    Steen NE; Methlie P; Lorentzen S; Hope S; Barrett EA; Larsson S; Mork E; Almås B; Løvås K; Agartz I; Melle I; Berg JP; Andreassen OA
    J Clin Psychiatry; 2011 Nov; 72(11):1515-21. PubMed ID: 21367348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis.
    Girshkin L; Matheson SL; Shepherd AM; Green MJ
    Psychoneuroendocrinology; 2014 Nov; 49():187-206. PubMed ID: 25108162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perisylvian GABA levels in schizophrenia and bipolar disorder.
    Atagün Mİ; Şıkoğlu EM; Soykan Ç; Serdar Süleyman C; Ulusoy-Kaymak S; Çayköylü A; Algın O; Phillips ML; Öngür D; Moore CM
    Neurosci Lett; 2017 Jan; 637():70-74. PubMed ID: 27890741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Expression of Proteins Associated with Bipolar Disorder as Identified Using the PeptideShaker Software.
    Seregin AA; Smirnova LP; Dmitrieva EM; Zavialova MG; Simutkin GG; Ivanova SA
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative genomic study in schizophrenic and in bipolar disorder patients, based on microarray expression profiling meta-analysis.
    Logotheti M; Papadodima O; Venizelos N; Chatziioannou A; Kolisis F
    ScientificWorldJournal; 2013; 2013():685917. PubMed ID: 23554570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: A potential mediator between mitochondria and immune-activation.
    Kim HK; Andreazza AC; Elmi N; Chen W; Young LT
    J Psychiatr Res; 2016 Jan; 72():43-50. PubMed ID: 26540403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circuit- and Diagnosis-Specific DNA Methylation Changes at γ-Aminobutyric Acid-Related Genes in Postmortem Human Hippocampus in Schizophrenia and Bipolar Disorder.
    Ruzicka WB; Subburaju S; Benes FM
    JAMA Psychiatry; 2015 Jun; 72(6):541-51. PubMed ID: 25738424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.